This announcement is a separate document:
沃森生物：关于子公司收到13价肺炎球菌多糖结合疫苗阿曼产品注册证的公告
Watson Biotech: Announcement on the subsidiary receiving the Oman Product Registration Certificate for the 13-valent pneumococcal polysaccharide conjugate vaccine
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.